Gemigliptin: all 33 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.CompletedNCT07399470Phase 1
- Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 DiabetesStatus unknownNCT05663736Phase 4
- Gemigliptin and Biomarkers of Kidney Injury and Vascular CalcificationCompletedNCT04705506Not applicable
- Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.CompletedNCT04317703Phase 1
- A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin AloneStatus unknownNCT04255238Phase 3
- Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.Status unknownNCT04050098Phase 1
- An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)CompletedNCT03864432Phase 1
- A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)CompletedNCT03842267Phase 3
- Gemigliptin, Dapagliflozin, Empagliflozin DDI StudyStatus unknownNCT03565458Phase 1
- An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican VolunteersCompletedNCT03310749Phase 1
- Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)CompletedNCT03202563Phase 4
- Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)CompletedNCT02831361Phase 3
- BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered AloneStatus unknownNCT02670070Phase 1
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered AloneStatus unknownNCT02670018Phase 1
- Initial Combination of Gemigliptin and Metformin on Microbiota ChangeCompletedNCT02609815Not applicable
- Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM PatientsStatus unknownNCT02500329Phase 4
- Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney InjuryStatus unknownNCT02250872Phase 2/3
- Effect of Gemigliptin on Metabolic Endotoxemia and LipemiaCompletedNCT02186080Not applicable
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.CompletedNCT02056600Phase 1
- Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White VolunteersCompletedNCT02004587Phase 1
- Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and MetforminCompletedNCT01990469Phase 3
- A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)CompletedNCT01968044Phase 3
- Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)CompletedNCT01890629Phase 4
- Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male SubjectsCompletedNCT01825850Phase 1
- Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.dCompletedNCT01787396Phase 3
- Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male SubjectsCompletedNCT01768455Phase 1
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered AloneCompletedNCT01662674Phase 1
- Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444CompletedNCT01603238Phase 1
- Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 DiabetesCompletedNCT01602003Phase 3
- Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 DiabetesCompletedNCT01601990Phase 3
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered AloneCompletedNCT01595880Phase 1
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01426399Phase 1
- Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male SubjectsCompletedNCT01001013Phase 1